February 2018 News & Views: PIE Act Is Now Before the Full E&C Committee; CEO Blog: PIE Act Addresses Lag Between FDA Approval, Patient Access; VIDEO: Academy Urges Passage of PIE Act
Leg-Reg Briefing February 2018: PIE Act Before Full House Energy & Commerce Committee AMCP Signs Joint Leer Supporting CREATES Act Bipartisan Budget Act of 2018 Addresses Part D Coverage Gap
On February 1, 2018, CMS released its 2019 Draft Call Letter. AMCP prepared in initial summary of the highlights contained in the Draft Call Letter. Of particular interest to AMCP members, CMS proposed new strategies for identifying potential opioid abuse which will work with the proposed codification of the current Opioid Monitoring System (OMS) under the Comprehensive Addiction and Recovery Act of 2015 (CARA).
The Academy of Managed Care Pharmacy (AMCP) thanks the FDA for the opportunity to provide comments before the Opioid Policy Steering Committee. AMCP commends the FDA for establishing the OPSC and for seeking public input to help identify key areas of focus that the FDA can address.
On January 30, 2018, AMCP delivered remarks to the FDA at an opioid policy steering committee meeting. AMCP commended the FDA for establishing the OPSC and for seeking public input to help identify key areas of focus that the FDA can address. AMCP focused on the following three areas; REMS; Labeling, Packaging, Storage, and Disposal; and Additional Focus Areas where AMCP feels that the FDA can be actively involved in combating the opioid epidemic.